The timing of the release coincided with their briefing. It was right on time. If it was, like srne's pump, it would do the company and shareholders a disservice. Too many flippers. PR's such as this are perfect for long term sustainment of share price. Remember Biocryst is followed by major analysts. All going as planned
Market Data 
Markets 
AI
